Exiqon AS Product Pipeline Analysis, 2017 Update [Report Updated: 08062017] Prices from USD $750

23:34 EDT 3 Aug 2017 | BioPortfolio Reports


Exiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products. Its microRNA research products comprise RNA isolation kits, microRNA sequencing kits, microRNA microarray analysis, universal RT microRNA PCR, microRNA detection probes, ISH detection probes and ISH kits, and functional analysis. Exiqon offers services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service. The company's products find applications in isolation, microarray analysis, northern blotting, realtime PCR, in situ hybridization, functional analysis and SNP detection. It operates in Denmark and the US. Exiqon is headquartered in Vedbaek, Denmark.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Exiqon AS
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Original Article: Exiqon AS Product Pipeline Analysis, 2017 Update [Report Updated: 08062017] Prices from USD $750


More From BioPortfolio on "Exiqon AS Product Pipeline Analysis, 2017 Update [Report Updated: 08062017] Prices from USD $750"

Quick Search

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

MicroRNAs (miRNAs)
A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals, and some viruses.  Key findings: miRNA is involved in the normal functioning of eukaryotic cells, so has dysregulation...